Complete financial analysis of PsyBio Therapeutics Corp. (PSYB.V) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of PsyBio Therapeutics Corp., a leading company in the Biotechnology industry within the Healthcare sector.
You may be interested
- REM Group (Holdings) Limited (1750.HK) Income Statement Analysis – Financial Results
- HyreCar Inc. (HYRE) Income Statement Analysis – Financial Results
- CareRx Corporation (CRRX.TO) Income Statement Analysis – Financial Results
- Enjin Co., Ltd. (7370.T) Income Statement Analysis – Financial Results
- Bitech Technologies Corporation (BTTC) Income Statement Analysis – Financial Results
PsyBio Therapeutics Corp. (PSYB.V)
About PsyBio Therapeutics Corp.
PsyBio Therapeutics Corp., a biotechnology company, focuses on the research, development, and commercialization of psychedelic-inspired regulated medicines for the treatment of mental health and other disorders in the United States. The company is headquartered in Coconut Creek, Florida.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 50.00K | 62.50K | 1.53M | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | -50.00K | -62.50K | -1.53M | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 390.14K | 622.80K | 54.55K | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 3.95M | 8.90M | 991.94K | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 3.85K | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 3.95M | 8.90M | 4.85M | 38.97K | 20.86K | 39.85K | 77.04K |
| Other Expenses | 28.11K | 89.65K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 4.41M | 9.61M | 4.90M | 38.97K | 20.86K | 39.85K | 77.04K |
| Cost & Expenses | 4.55M | 9.67M | 6.44M | 38.97K | 20.86K | 39.85K | 77.04K |
| Interest Income | 6.56K | 31.51K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 21.05K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 146.05K | 9.04M | 6.44M | 171.86K | 161.14K | 0.00 | 0.00 |
| EBITDA | -4.53M | 0.00 | 0.00 | -16.16K | -20.86K | -39.85K | -77.04K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -4.55M | -8.23M | -6.44M | -38.97K | -20.86K | -39.85K | -77.04K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -331.34K | -1.98M | 353.00 | 22.81K | -1.00 | -3.00 | 20.18K |
| Income Before Tax | -4.89M | -11.02M | -6.44M | -16.16K | -20.86K | -39.85K | -56.86K |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 1.43M | 0.35 | -171.86K | -161.14K | 0.00 | 0.00 |
| Net Income | -4.89M | -11.02M | -6.44M | -16.16K | -20.86K | -39.85K | -56.86K |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.04 | -0.10 | -0.20 | 0.00 | -0.01 | -0.02 | -0.04 |
| EPS Diluted | -0.04 | -0.10 | -0.20 | 0.00 | -0.01 | -0.02 | -0.04 |
| Weighted Avg Shares Out | 111.81M | 106.94M | 31.59M | 0.00 | 2.36M | 2.33M | 1.44M |
| Weighted Avg Shares Out (Dil) | 111.81M | 106.94M | 31.59M | 0.00 | 2.36M | 2.33M | 1.44M |
No news found for: PSYB.V
Source: https://incomestatements.info
Category: Stock Reports